Zoetis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. 

CEO
Kristin C. Peck
CEOKristin C. Peck
Employees
14,500
Employees14,500
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
1952
Founded1952
Employees
14,500
Employees14,500

ZTS Key Statistics

Market cap
31.19B
Market cap31.19B
Price-Earnings ratio
12.77
Price-Earnings ratio12.77
Dividend yield
2.71%
Dividend yield2.71%
Average volume
5.37M
Average volume5.37M
High today
$76.69
High today$76.69
Low today
$72.47
Low today$72.47
Open price
$76.09
Open price$76.09
Volume
10.09M
Volume10.09M
52 Week high
$160.48
52 Week high$160.48
52 Week low
$71.47
52 Week low$71.47

Stock Snapshot

Zoetis(ZTS) stock is priced at $73.10, giving the company a market capitalization of 31.19B. It carries a P/E multiple of 12.77 and pays a dividend yield of 2.71%.

On 2026-08-05, Zoetis(ZTS) stock traded between a low of $72.47 and a high of $76.69. Shares are currently priced at $73.10, which is +0.9% above the low and -4.7% below the high.

The Zoetis(ZTS)'s current trading volume is 10.09M, compared to an average daily volume of 5.37M.

In the last year, Zoetis(ZTS) shares hit a 52-week high of $160.48 and a 52-week low of $71.47.

In the last year, Zoetis(ZTS) shares hit a 52-week high of $160.48 and a 52-week low of $71.47.

ZTS News

TipRanks 6h
Zoetis put volume heavy and directionally bearish

Bearish flow noted in Zoetis (ZTS) with 3,517 puts trading, or 3x expected. Most active are Aug-26 60 puts and Aug-26 70 puts, with total volume in those strike...

MarketWatch 1d
Zoetis Inc. stock underperforms Tuesday when compared to competitors - marketwatch.com

...

Zoetis Inc. stock underperforms Tuesday when compared to competitors - marketwatch.com
Nasdaq 2d
ZTS Set to Report Q2 Earnings: Here's What Investors Should Expect

Zoetis, Inc. ZTS is slated to report second-quarter results on Aug. 6, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quart...

ZTS Set to Report Q2 Earnings: Here's What Investors Should Expect

Analyst ratings

50%

of 20 ratings
Buy
50%
Hold
50%
Sell
0%

More ZTS News

Simply Wall St 4d
Zoetis In Focus On Burry Buying As Investors Weigh An Undervalued Story

Zoetis (ZTS) is back in focus after Michael Burry increased his position in the stock, just as the animal health company heads toward an early August earnings r...

Zoetis In Focus On Burry Buying As Investors Weigh An Undervalued Story

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.